Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania is entering a new stage, with its multiannual economic recovery programme launching in 2026, carrying an estimated budget of around €5 billion through 2032 and a dedicated framework for anchor-type strategic investments above €200 million, according to experts at EY Romania.
FintechOS, the financial technology company founded in Romania that provides AI-based digitalisation solutions for banks and insurers, has reached profitability on the back of a 40% rise in recurring revenue at the end of Q1, company representatives said.
OMV Petrom, an integrated energy producer in Southeast Europe, has made the final investment decision for Gabare, an integrated solar energy and battery storage project in Bulgaria.
Romania has reached 31 da Vinci robotic surgery programs nationwide, of which 8 are in the public healthcare system. The most recent system, installed at Fundeni Clinical Institute, marks the expansion of robotic surgery in Romanian public hospitals and the regional milestone of 100 da Vinci systems across the SOFMEDICA region: Romania, Greece, Bulgaria, Hungary, Cyprus, Croatia and Slovenia.
The gap between European and Romanian agricultural economic pressures widened in Q1 2026.